UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019

The Journal of urology, 2019-09, Vol.202 (3), p.558-563

2019

Volltextzugriff (PDF)

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

European urology, 2013-08, Vol.64 (2), p.249-256

2013

Volltextzugriff (PDF)

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline

The Journal of urology, 2012-12, Vol.188 (6), p.2455-2463

2012

Volltextzugriff (PDF)

Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity

The Journal of clinical investigation, 2020-05, Vol.130 (5), p.2209-2219

2020

Volltextzugriff (PDF)

Effect of Pharmacotherapy for Overactive Bladder on the Incidence of and Factors Related to Urinary Tract Infection: A Systematic Review and Meta-analysis

The Journal of urology, 2023-04, Vol.209 (4), p.665-674

2023

Volltextzugriff (PDF)

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

European urology, 2015-03, Vol.67 (3), p.577-588

2015

Volltextzugriff (PDF)

Dementia Associated with Anticholinergic Drugs Used for Overactive Bladder: A Nested Case-Control Study Using the French National Medical-Administrative Database

The Journal of urology, 2022-10, Vol.208 (4), p.863-871

2022

Volltextzugriff (PDF)

Anticholinergic Drugs for Adult Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis

European urology, 2012-11, Vol.62 (5), p.816-830

2012

Volltextzugriff (PDF)

Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder

Neurourology and urodynamics, 2016-02, Vol.35 (2), p.246-251

2016

Volltextzugriff (PDF)

Machine Learning for Urodynamic Detection of Detrusor Overactivity

Urology (Ridgewood, N.J.), 2022-01, Vol.159, p.247-254

2022

Volltextzugriff (PDF)

Patient‐reported reasons for discontinuing overactive bladder medication

BJU international, 2010-05, Vol.105 (9), p.1276-1282

2010

Volltextzugriff (PDF)

Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS

Urology (Ridgewood, N.J.), 2012-07, Vol.80 (1), p.90-96

2012

Volltextzugriff (PDF)

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Neurourology and urodynamics, 2014-01, Vol.33 (1), p.17-30

2014

Volltextzugriff (PDF)

Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder

Neurourology and urodynamics, 2014-07, Vol.33 (S3), p.S2-S5

Haab, Francois

2014

Volltextzugriff (PDF)

Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Detrusor Hyperactivity with Impaired Contractility via Transient Potential Vanilloid Channels: A Rat Model for Ovarian Hormone Deficiency

International journal of molecular sciences, 2024-05, Vol.25 (9), p.4927

2024

Volltextzugriff (PDF)

Effectiveness of Combined Behavioral and Drug Therapy for Overactive Bladder Symptoms in Men: A Randomized Clinical Trial

JAMA internal medicine, 2020-03, Vol.180 (3), p.411

2020

Volltextzugriff (PDF)

Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology

American journal of physiology. Regulatory, integrative and comparative physiology, 2014-09, Vol.307 (6), p.R571-R584

Petkov, Georgi V

2014

Volltextzugriff (PDF)

Detrusor Acontractility after Acute Spinal Cord Injury—Myth or Reality?

The Journal of urology, 2018-06, Vol.199 (6), p.1565-1570

2018

Volltextzugriff (PDF)

Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)

European urology, 2012-09, Vol.62 (3), p.507-514

2012

Volltextzugriff (PDF)

Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial

European urology, 2019-02, Vol.75 (2), p.274-282

2019

Volltextzugriff (PDF)

Treatment for overactive bladder: A meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation

Medicine (Baltimore), 2021-05, Vol.100 (20), p.e25941-e25941

2021

Volltextzugriff (PDF)

A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction

The Journal of urology, 2015-03, Vol.193 (3), p.921-926

2015

Volltextzugriff (PDF)

Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management

Parkinsonism & related disorders, 2017-02, Vol.35, p.8-16

2017

Volltextzugriff (PDF)

The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients

Age and ageing, 2014-09, Vol.43 (5), p.666-675

2014

Volltextzugriff (PDF)

1 – 25 von 7.081

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.434)
Mit Volltextzugriff
(5.399)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.615)
Life Sciences & Biomedicine
(5.524)
Humans
(5.208)
Female
(3.694)
Urology & Nephrology
(3.496)
Overactive Bladder
(2.902)
Male
(2.598)
Middle Aged
(2.273)
Urinary Bladder, Overactive - Drug Therapy
(2.253)
Aged
(2.024)
Urology
(1.731)
Adult
(1.680)
Urinary Incontinence
(1.664)
Treatment Outcome
(1.499)
Urinary Bladder, Overactive - Physiopathology
(1.368)
Bladder
(1.193)
Quality Of Life
(1.145)
Urinary Bladder, Overactive - Therapy
(968)
Urodynamics
(967)
Urinary Bladder
(929)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neurourology And Urodynamics
(720)
The Journal Of Urology
(438)
International Urogynecology Journal
(319)
Bju International
(281)
European Urology
(241)
Urology
(230)
International Journal Of Urology
(157)
International Urogynecology Journal And Pelvic Floor Dysfunction
(120)
Progrès En Urologie
(106)
Current Urology Reports
(102)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019

European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline

Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity

Effect of Pharmacotherapy for Overactive Bladder on the Incidence of and Factors Related to Urinary Tract Infection: A Systematic Review and Meta-analysis

Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)

Dementia Associated with Anticholinergic Drugs Used for Overactive Bladder: A Nested Case-Control Study Using the French National Medical-Administrative Database

Anticholinergic Drugs for Adult Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis

Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder

Machine Learning for Urodynamic Detection of Detrusor Overactivity

Patient‐reported reasons for discontinuing overactive bladder medication

Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS

Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability

Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder

Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Detrusor Hyperactivity with Impaired Contractility via Transient Potential Vanilloid Channels: A Rat Model for Ovarian Hormone Deficiency

Effectiveness of Combined Behavioral and Drug Therapy for Overactive Bladder Symptoms in Men: A Randomized Clinical Trial

Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology

Detrusor Acontractility after Acute Spinal Cord Injury—Myth or Reality?

Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)

Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial

Treatment for overactive bladder: A meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation

A Randomized Controlled Study of the Efficacy of Tamsulosin Monotherapy and its Combination with Mirabegron for Overactive Bladder Induced by Benign Prostatic Obstruction

Lower urinary tract symptoms in Parkinson's disease: Prevalence, aetiology and management

The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients

Suchergebnisse filtern